|This article needs additional citations for verification. (November 2007) (Learn how and when to remove this template message)|
|3D model (Jmol)||Interactive image|
|Molar mass||253.36 g/mol|
|Melting point||203.5 to 204.5 °C (398.3 to 400.1 °F; 476.6 to 477.6 K)|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|what is ?)(|
2C-T-15 or 2,5-dimethoxy-4-(β-cyclopropylthio)phenethylamine is a psychedelic phenethylamine of the 2C family. It was presumably first synthesized by Alexander Shulgin and reported in his book PiHKAL (Phenethylamines i Have Known And Loved).
2C-T-15 is the 2 carbon homologue of Aleph-15, which has not been synthesized. The full chemical name is 2-[4-(2-cyclopropylthio)-2,5-dimethoxyphenyl]ethanamine. The drug has structural properties similar to 2C-T-2 and other drugs in the 2C-T series.
The dosage range of 2C-T-15 is typically 30 mg or more. Its duration is unspecified by Shulgin, and its entry in PiHKAL says it lasts for "several hours." The effects are not prominent, and 2C-T-15 is not very potent.
The mechanism that produces 2C-T-15's hallucinogenic and entheogenic effects has not been specifically established, however it is most likely to result from action as a 5-HT2A serotonin receptor agonist in the brain, a mechanism of action shared by all of the hallucinogenic tryptamines and phenethylamines for which the mechanism of action is known.
The toxicity of 2C-T-15 is not well documented. 2C-T-15 is much less potent than 2C-T-7, but it may be expected that at very high doses it would display similar toxicity to that of other phenethylamines of the 2C-T family.
2C-T-15 is a class A drug in the UK under the Misuse of Drugs act.
As of October 31st, 2016; 2C-T-15 is a controlled substance (Schedule III) in Canada. http://gazette.gc.ca/rp-pr/p2/2016/2016-05-04/html/sor-dors72-eng.php